ArticleJournal of hepatocellular carcinoma2026
Multimodal Modeling Distinguishes Treatment Response from Overall Survival in Hepatocellular Carcinoma Receiving Combined Interventional and Targeted Immunotherapy.
Donghai Lu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.